Skip to main content

Featured

Canada's Housing Market Just Showed Its Strongest Sign of Life in 2026

  July 6, 2026 May sales jumped 5.5% nationally, listings tightened, and prices broke back above $700,000 — here's what it actually means if you're buying or selling in Ontario. The headline: After the slowest start to a year in recent memory, Canadian home sales rose 5.5% from April to May 2026 — the first real sign of momentum this year, according to the Canadian Real Estate Association (CREA). What actually happened in May National home sales climbed 5.5% month-over-month in May, the strongest single-month gain of 2026 so far. New listings pulled back slightly, down 1%, and that combination tightened the national sales-to-new-listings ratio to 49.2%, up from 46.2% in April. For context, anything between 45% and 65% is generally considered a balanced market, so Canada has moved off the buyer-friendly end of that range and toward the middle. The national average home price came in at $702,079, up 1.5% year-over-year and the first time it has topped $700,000 in nearly two year...

article

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Comments